Your Alzheimer’s questions, answered

If you’ve ever wondered about the difference between plaques and oligomers, between alpha synuclein and tau, or just what BACE stands for, we have answers for you.

Yesterday, STAT’s Sharon Begley and Matthew Herper spent a few hours fielding all manner of questions about the state of Alzheimer’s disease research, including the fate of the amyloid hypothesis and the role of bacteria in neurodegeneration. They talked about novel therapeutic targets, genetic testing, and how the immune system intersects with Alzheimer’s.

If you missed it (or just want to relive it), you can find the archive here.